nodes	percent_of_prediction	percent_of_DWPC	metapath
Lucanthone—APEX1—cardiac ventricle—dilated cardiomyopathy	0.1	0.186	CbGeAlD
Lucanthone—APEX1—myocardium—dilated cardiomyopathy	0.0942	0.175	CbGeAlD
Lucanthone—TOP1—cardiac ventricle—dilated cardiomyopathy	0.0701	0.13	CbGeAlD
Lucanthone—TOP1—myocardium—dilated cardiomyopathy	0.0659	0.123	CbGeAlD
Lucanthone—APEX1—heart—dilated cardiomyopathy	0.0658	0.122	CbGeAlD
Lucanthone—APEX1—cardiac atrium—dilated cardiomyopathy	0.0562	0.105	CbGeAlD
Lucanthone—TOP1—heart—dilated cardiomyopathy	0.046	0.0856	CbGeAlD
Lucanthone—Cinchocaine—SCN5A—dilated cardiomyopathy	0.0398	0.47	CrCbGaD
Lucanthone—TOP1—Circadian rythm related genes—SIK1—dilated cardiomyopathy	0.0395	0.113	CbGpPWpGaD
Lucanthone—TOP1—cardiac atrium—dilated cardiomyopathy	0.0393	0.0732	CbGeAlD
Lucanthone—TOP1—Caspase Cascade in Apoptosis—LMNA—dilated cardiomyopathy	0.0303	0.0869	CbGpPWpGaD
Lucanthone—TOP2A—Methyltestosterone—Spironolactone—dilated cardiomyopathy	0.0286	1	CbGdCrCtD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.0216	0.0619	CbGpPWpGaD
Lucanthone—Procainamide—SCN5A—dilated cardiomyopathy	0.0206	0.243	CrCbGaD
Lucanthone—TOP1—Caspase Cascade in Apoptosis—FASLG—dilated cardiomyopathy	0.0184	0.0527	CbGpPWpGaD
Lucanthone—TOP1—Caspase Cascade in Apoptosis—FAS—dilated cardiomyopathy	0.0177	0.0508	CbGpPWpGaD
Lucanthone—Amiodarone—ADRB1—dilated cardiomyopathy	0.0124	0.146	CrCbGaD
Lucanthone—TOP2A—Circadian rythm related genes—SIK1—dilated cardiomyopathy	0.0123	0.0353	CbGpPWpGaD
Lucanthone—Procainamide—SLC22A5—dilated cardiomyopathy	0.0119	0.14	CrCbGaD
Lucanthone—APEX1—Spinal Cord Injury—CXCL2—dilated cardiomyopathy	0.0116	0.0332	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—RPS6KB1—dilated cardiomyopathy	0.0116	0.0331	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—TUBB—dilated cardiomyopathy	0.00866	0.0248	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—GJA1—dilated cardiomyopathy	0.0086	0.0247	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—TUBB—dilated cardiomyopathy	0.00774	0.0222	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—EMD—dilated cardiomyopathy	0.00772	0.0221	CbGpPWpGaD
Lucanthone—TOP1—Caspase Cascade in Apoptosis—TNF—dilated cardiomyopathy	0.00752	0.0216	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—ALMS1—dilated cardiomyopathy	0.00726	0.0208	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.00699	0.02	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—RAF1—dilated cardiomyopathy	0.00692	0.0198	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—EMD—dilated cardiomyopathy	0.0069	0.0198	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.00675	0.0193	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.00674	0.0193	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.0066	0.0189	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—RAC1—dilated cardiomyopathy	0.00656	0.0188	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—ALMS1—dilated cardiomyopathy	0.00649	0.0186	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.00647	0.0185	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—TMPO—dilated cardiomyopathy	0.00459	0.0132	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.00438	0.0125	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—TMPO—dilated cardiomyopathy	0.0041	0.0118	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 2—EGFR—dilated cardiomyopathy	0.00402	0.0115	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—TUBB—dilated cardiomyopathy	0.00401	0.0115	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—LMNA—dilated cardiomyopathy	0.00377	0.0108	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—TUBB—dilated cardiomyopathy	0.00358	0.0103	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—EMD—dilated cardiomyopathy	0.00357	0.0102	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—LMNA—dilated cardiomyopathy	0.00337	0.00966	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—ALMS1—dilated cardiomyopathy	0.00336	0.00962	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—EMD—dilated cardiomyopathy	0.00319	0.00915	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	0.003	0.0086	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—ALMS1—dilated cardiomyopathy	0.003	0.0086	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—EGFR—dilated cardiomyopathy	0.00298	0.00854	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	0.00286	0.00819	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—TNF—dilated cardiomyopathy	0.00284	0.00814	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—RAF1—dilated cardiomyopathy	0.00257	0.00735	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.00218	0.00625	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—TMPO—dilated cardiomyopathy	0.00212	0.00608	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.0021	0.00603	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.00206	0.00591	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.00202	0.00579	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—TMPO—dilated cardiomyopathy	0.0019	0.00544	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—LMNA—dilated cardiomyopathy	0.00174	0.005	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—LMNA—dilated cardiomyopathy	0.00156	0.00447	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.00137	0.00392	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	0.000938	0.00269	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	0.000893	0.00256	CbGpPWpGaD
